209 related articles for article (PubMed ID: 9589354)
21. Biomarker and cytologic abnormalities in women at high and low risk for breast cancer.
Fabian CJ; Zalles C; Kamel S; McKittrick R; Moore WP; Zeiger S; Simon C; Kimler B; Cramer A; Garcia F
J Cell Biochem Suppl; 1993; 17G():153-60. PubMed ID: 7911861
[TBL] [Abstract][Full Text] [Related]
22. Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer.
Mohsin SK; Allred DC; Osborne CK; Cruz A; Otto P; Chew H; Clark GM; Elledge RM
Breast Cancer Res Treat; 2005 Dec; 94(3):205-11. PubMed ID: 16267611
[TBL] [Abstract][Full Text] [Related]
23. Breast-tissue sampling for risk assessment and prevention.
Fabian CJ; Kimler BF; Mayo MS; Khan SA
Endocr Relat Cancer; 2005 Jun; 12(2):185-213. PubMed ID: 15947097
[TBL] [Abstract][Full Text] [Related]
24. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
25. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.
Mitchell G; Antill YC; Murray W; Kirk J; Salisbury E; Lindeman GJ; Di Iulio J; Milner AD; Devereaux L; Phillips KA
Breast Cancer Res; 2005; 7(6):R1122-31. PubMed ID: 16457692
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer risk factors in younger and older women.
Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
[TBL] [Abstract][Full Text] [Related]
27. Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
Frank DH; Kimler BF; Fabian CJ; Ranger-Moore J; Yozwiak M; Bartels HG; Alberts DS; Bartels PH
Breast Cancer Res Treat; 2009 Jun; 115(3):661-8. PubMed ID: 19125322
[TBL] [Abstract][Full Text] [Related]
28. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
Mridha AR; Iyer VK; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
30. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
31. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
[TBL] [Abstract][Full Text] [Related]
32. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
Maru D; Middleton LP; Wang S; Valero V; Sahin A
Cancer; 2005 Mar; 103(5):900-5. PubMed ID: 15643600
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
34. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
[TBL] [Abstract][Full Text] [Related]
35. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
36. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
[TBL] [Abstract][Full Text] [Related]
37. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
38. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer.
Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329
[TBL] [Abstract][Full Text] [Related]
39. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
40. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]